Evolus, Inc. (EOLS) Stock Forecast
EOLS analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 6 analysts
- Price target
- $15.00 average of analyst targets
- Upside to target
- +111.3% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-0.14
- 52-week range
- $3.94 – $9.30
EOLS analyst ratings
6 analystsNumber of analysts at each rating.
EOLS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
EOLS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.07 | −$0.08 | −$0.06 | −$0.15 | +54.3% | 4 |
| Current fiscal year (2026) | −$0.05 | −$0.10 | −$0.03 | −$0.44 | +89.2% | 4 |
| Next fiscal year (2027) | $0.29 | $0.21 | $0.38 | −$0.05 | +715.8% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
EOLS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $77.6M | $76.8M | $78.3M | +12.5% | 6 |
| Current fiscal year (2026) | $334.2M | $333.0M | $335.9M | +12.4% | 6 |
| Next fiscal year (2027) | $392.2M | $372.9M | $403.4M | +17.4% | 6 |
EOLS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
EOLS revenue: reported and forecast
EOLS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.07 | −$0.06 | −$0.06 | −$0.06 | −$0.07 | −3.6% | 2 up · 1 down |
| Current fiscal year (2026) | −$0.09 | −$0.04 | −$0.04 | −$0.05 | −$0.05 | −49.5% | 5 up · 0 down |
| Next fiscal year (2027) | $0.24 | $0.26 | $0.28 | $0.29 | $0.29 | +21.9% | 4 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
EOLS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; EOLS beat in 5 of 12.
What analysts expect from EOLS
6 analysts cover Evolus; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $15.00, 111.3% above the latest close of $7.10. Analysts expect earnings of −$0.05 per share for 2026, +89.2% from a year earlier. For 2027 the average estimate is $0.29 per share on revenue of $392.2 million. Evolus beat the EPS estimate in 5 of the last 12 quarters.
Related: EOLS income statement, EOLS key metrics, EOLS chart. See the EOLS stock overview for the latest quote and news.
EOLS forecast FAQ
What is Evolus's price target?
The average analyst price target for Evolus is $15.00, 111.3% above the latest close of $7.10.
Is Evolus a buy, hold or sell?
Of 6 analysts covering Evolus, 4 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Evolus's EPS forecast?
Analysts forecast −$0.05 per share for 2026 (range −$0.10 to −$0.03); for 2027 the estimate is $0.29.
What is Evolus's revenue forecast?
The average revenue estimate for 2026 is $334.2 million, growth of 12.4%; for 2027 it is $392.2 million.
When does Evolus report earnings?
Evolus is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $-0.14.
Does Evolus usually beat earnings estimates?
Evolus reported EPS at or above the analyst estimate in 5 of the last 12 quarters.